AD-34-WD27_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, 7-Bromo-1,2,3,4-tetrahydroisoquinoline, Phenylethanolamine N-methyltransferase inhibitor targeting PNMT (Novartis, 10729255)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/10729255
Similar Terms
Downloads & Tools

Genes

13 genes differentially expressed following the AD-34-WD27_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
SYT4 synaptotagmin IV 0.766391
CFHR1 complement factor H-related 1 0.373263
RPS15 ribosomal protein S15 0.345404
RPS9 ribosomal protein S9 0.339345

decreased expression

Symbol Name Standardized Value
XPNPEP1 X-prolyl aminopeptidase (aminopeptidase P) 1, soluble -0.339345
UBASH3B ubiquitin associated and SH3 domain containing B -0.278179
MED10 mediator complex subunit 10 -0.27436
UBXN2B UBX domain protein 2B -0.27436
DUSP7 dual specificity phosphatase 7 -0.274089
SRF serum response factor (c-fos serum response element-binding transcription factor) -0.228828
GDF11 growth differentiation factor 11 -0.217064
MCC mutated in colorectal cancers -0.209515
PRKAR1A protein kinase, cAMP-dependent, regulatory, type I, alpha -0.204574